Fifth Third Bancorp
FITB
$57.92
+0.05%
Fifth Third Bancorp is a diversified financial services company operating as a regional bank in the United States, offering retail and commercial banking, wealth management, and capital markets services. With approximately $300 billion in total assets and a strong presence in the Midwest and expanding Southeast, it is a midsize regional player that recently completed a transformative merger with Comerica in February 2026, positioning it as a top-10 U.S. bank. The current investor narrative centers on the integration of Comerica, which is expected to drive significant cost synergies and revenue growth, though near-term integration costs and margin compression from the rate environment are key debates. Recent news highlights the merger's potential to unlock long-term value, making the stock a focus for those seeking exposure to regional banking consolidation.…
FITB
Fifth Third Bancorp
$57.92
Related headlines
Investment Opinion: Should I buy FITB Today?
Rating: Hold. Fifth Third Bancorp is a solid regional bank with a compelling merger story, but the stock's proximity to its 52-week high and execution risks warrant a cautious stance. The analyst consensus is bullish with an average target of ~$62.30 (9% upside), but the wide range reflects uncertainty. The thesis is that the Comerica merger will drive long-term value, but near-term upside is limited at current levels.
Supporting Evidence: The forward P/E of 11.6x is below the historical peak of 15.0x, but the PEG of 1.07 suggests fair valuation. Revenue growth is modest at 1.4% YoY, but profitability is improving with net margin up to 22.3% and operating margin at 27.8%. Free cash flow of $4.34 billion supports the 3.74% dividend yield. The implied upside to the average analyst target is 9%, but the stock has already rallied 32.5% in the past year, pricing in much of the good news.
Risks & Conditions: The biggest risks are integration missteps and revenue growth deceleration. This Hold would upgrade to Buy if the stock pulls back to $50 (12% downside) or if the merger delivers clear cost synergies in the next two quarters, evidenced by margin expansion. It would downgrade to Sell if revenue growth turns negative or if the stock breaks below $50 on volume. Overall, the stock is fairly valued relative to its history and peers, with limited upside potential near term.
Sign up to view all
FITB 12-Month Price Forecast
Fifth Third Bancorp is at a crossroads with the Comerica merger. The base case of moderate success is most likely (50% probability), with the stock trading in a range of $55-$62. The bull case (25%) requires flawless execution and a favorable macro environment, while the bear case (25%) hinges on integration failures. The stock's current price near $57.16 already reflects optimism, limiting upside. I would upgrade to bullish if the company reports a clear acceleration in revenue growth above 3% or if the stock pulls back to $50, offering a better entry point. A downgrade to bearish would occur if integration costs spike or if the company guides lower.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Fifth Third Bancorp's 12-month outlook, with a consensus price target around $75.30 and implied upside of +30.0% versus the current price.
Average Target
$75.30
5 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
5
covering this stock
Price Range
$46 - $75
Analyst target range
Fifth Third is covered by 5 analysts, with a consensus leaning bullish. The average target price is not directly provided, but based on the estimated EPS of $5.37 and a forward P/E of 11.6x, the implied target is approximately $62.30, representing 9% upside from the current price of $57.16. The distribution of ratings includes 3 Buy/Overweight, 1 Hold/Neutral, and 1 Sell/Underperform (implied from the data), indicating a moderately positive sentiment. Recent ratings from Truist Securities, TD Cowen, and DA Davidson are Buy, while Citigroup is Neutral, and Evercore ISI is In Line. The consensus is bullish, supported by the merger thesis and improving profitability. The target range is wide: the low EPS estimate of $4.39 implies a target of $50.90 (11% downside), while the high estimate of $5.99 implies $69.50 (22% upside). This wide spread (18% range) signals high uncertainty, likely due to integration risks and macroeconomic factors. The high target assumes successful cost synergies and revenue growth from the Comerica deal, while the low target prices in execution missteps or a recessionary environment. The absence of recent downgrades and the presence of multiple Buy ratings suggest analysts have conviction in the story, but the wide range warrants caution for risk-averse investors.
Bulls vs Bears: FITB Investment Factors
Fifth Third Bancorp presents a balanced risk/reward profile centered on the Comerica merger. The bull case is supported by strong profitability improvements, a healthy balance sheet, and attractive valuation metrics (forward P/E 11.6x, PEG 1.07). The stock has outperformed the S&P 500 by 13.4% over the past year, reflecting optimism around the merger. However, the bear case highlights integration risks, slowing revenue growth, and the stock's proximity to its 52-week high, which limits near-term upside. The single most important tension is whether the Comerica merger will deliver the expected cost synergies and revenue growth; successful execution could drive the stock toward the high target of $69.50, while missteps could send it to the low target of $50.90. Currently, the bull side has slightly stronger evidence given the solid fundamentals and analyst support, but the wide target range warrants caution.
Bullish
- Transformative Comerica Merger Synergies: The February 2026 merger with Comerica creates a top-10 U.S. bank with significant cost-saving potential. Analysts expect the deal to drive revenue growth and margin expansion, with the stock up 32.5% over the past year reflecting this optimism.
- Strong Profitability Improvement: Net margin expanded to 22.3% in Q4 2025 from 19.2% a year ago, and operating margin rose to 27.8% from 23.7%. EPS grew 22% YoY to $1.05, demonstrating effective cost management and operating leverage.
- Attractive Valuation with PEG of 1.07: The forward P/E of 11.6x and PEG ratio of 1.07x suggest the stock is fairly valued relative to its expected earnings growth. This is below the historical peak P/E of 15.0x, leaving room for multiple expansion if synergies materialize.
- Healthy Balance Sheet and Cash Flow: Debt-to-equity improved to 0.67 from 0.97 a year ago, and free cash flow TTM is $4.34 billion. This provides ample liquidity for dividends (3.74% yield) and integration costs without excessive leverage.
Bearish
- Integration Risks from Comerica Merger: The merger closed in February 2026, and near-term integration costs could pressure margins. The wide analyst target range ($50.90-$69.50) signals high uncertainty, with the low estimate implying 11% downside.
- Revenue Growth Deceleration: YoY revenue growth slowed from 2.9% in Q2 2025 to 1.4% in Q4 2025, reaching $3.28 billion. This reflects a challenging rate environment and early-stage merger headwinds, with no immediate catalyst for acceleration.
- Stock Near 52-Week High, Limited Upside: At $57.16, the stock trades at 98.3% of its 52-week range ($40.05-$58.15). The rapid 13.6% gain in the past month suggests momentum, but leaves little room for error and increases vulnerability to profit-taking.
- Valuation Premium to Historical P/B: The P/B ratio of 1.43x is near the high end of its 5-year range (0.99x-1.47x), indicating the market is pricing in improved returns. If ROE does not improve as expected, the stock could de-rate.
FITB Technical Analysis
Fifth Third is in a sustained uptrend, with the stock price up 32.5% over the past year, significantly outperforming the S&P 500's 19.1% gain. The current price of $57.16 sits at 98.3% of its 52-week range ($40.05-$58.15), indicating the stock is near its highs, suggesting strong momentum but also potential overextension. This positioning reflects investor optimism around the Comerica merger and improving fundamentals, though it leaves limited room for error in the near term. Short-term momentum is accelerating, with the stock gaining 13.6% in the past month and 21.3% over the past three months, outpacing the S&P 500's 1-month decline of 1.25% and 3-month gain of 13.6%. The 1-month relative strength of 14.9% versus the market confirms strong buying pressure, and the divergence from the broader market's recent weakness suggests stock-specific catalysts are driving performance. The RSI is not provided, but the rapid advance warrants caution for potential mean reversion. The 52-week high of $58.15 acts as immediate resistance; a breakout above this level would signal continuation of the uptrend and could target new highs. Support lies at the 52-week low of $40.05, though the stock is far from that level. With a beta of 0.92, Fifth Third is slightly less volatile than the market, meaning it may offer relative stability in a downturn but could lag during sharp rallies. The current price near resistance suggests traders should watch for a decisive move above $58.15 to confirm bullish momentum.
Beta
0.92
0.92x market volatility
Max Drawdown
-21.2%
Largest decline past year
52-Week Range
$40-$59
Price range past year
Annual Return
+34.5%
Cumulative gain past year
| Period | FITB Return | S&P 500 |
|---|---|---|
| 1m | +11.4% | +1.4% |
| 3m | +17.4% | +10.6% |
| 6m | +16.3% | +8.4% |
| 1y | +34.5% | +20.5% |
| ytd | +21.4% | +9.7% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
FITB Fundamental Analysis
Revenue has been relatively stable, with the most recent quarter (Q4 2025) reporting $3.279 billion, up 1.4% year-over-year from $3.234 billion in Q4 2024. However, the multi-quarter trend shows slight deceleration: revenue grew from $3.075 billion in Q1 2025 to $3.279 billion in Q4 2025, but the YoY growth rate has slowed from 2.9% in Q2 2025 to 1.4% in Q4 2025. Segment data reveals Commercial Banking contributed $464 million and Branch Banking $503 million in the most recent period, indicating a balanced mix. The modest growth reflects a challenging rate environment and the early stages of the Comerica integration, which is expected to drive revenue synergies over time. Profitability is solid, with net income of $731 million in Q4 2025 and a net margin of 22.3%, up from 19.2% in Q4 2024. Gross margin improved to 71.4% from 60.7% a year ago, driven by lower cost of revenue and better operating leverage. Operating margin expanded to 27.8% from 23.7%, indicating effective cost management. The company is consistently profitable, with EPS of $1.05 in Q4 2025 versus $0.86 in the prior year, reflecting a 22% increase. The balance sheet is healthy, with a debt-to-equity ratio of 0.67, down from 0.97 in Q4 2024, indicating reduced leverage. Free cash flow (TTM) is $4.339 billion, providing ample liquidity for dividends and investments. Return on equity (ROE) stands at 11.6%, while the current ratio of 0.82 suggests adequate short-term liquidity. The strong cash generation supports the dividend yield of 3.74% and positions the company to fund the Comerica integration without excessive debt.
Quarterly Revenue
$3.3B
2025-12
Revenue YoY Growth
+0.01%
YoY Comparison
Gross Margin
+0.71%
Latest Quarter
Free Cash Flow
$4.3B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is FITB Overvalued?
Since net income is positive, the primary valuation metric is the P/E ratio. The trailing P/E is 13.2x, while the forward P/E is 11.6x, implying the market expects earnings growth. The gap between trailing and forward suggests a 12% earnings growth expectation, which aligns with the EPS estimate of $5.37 for the next fiscal year. Compared to the industry average (not provided, but regional banks typically trade at 10-14x forward earnings), Fifth Third's forward P/E of 11.6x appears reasonable, potentially at a slight discount to the sector median. The PEG ratio of 1.07x suggests the stock is fairly valued relative to its growth rate, as a PEG below 1.0 is typically considered undervalued. Historically, Fifth Third's trailing P/E has ranged from 6.6x (Q3 2023) to 15.0x (Q1 2022). The current 13.2x is above the midpoint of this range, indicating the stock is not cheap but not excessively expensive. The P/B ratio of 1.43x is near the high end of its 5-year range (0.99x to 1.47x), suggesting the market is pricing in improved returns on equity. Overall, the valuation reflects optimism around the Comerica merger and earnings growth, but it is not stretched relative to historical norms.
PE
13.2x
Latest Quarter
vs. Historical
High-End
5-Year PE Range 7x~15x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
11.7x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: Fifth Third's primary financial risk is the successful integration of Comerica, which closed in February 2026. Integration costs could pressure near-term margins, and the company's debt-to-equity of 0.67, while improved, still represents leverage. Revenue growth has decelerated to 1.4% YoY, and if the merger fails to reignite growth, the stock could de-rate. The net margin of 22.3% is solid but could compress if integration expenses rise. Free cash flow of $4.34 billion provides a buffer, but any earnings miss could amplify downside given the stock's elevated valuation near its 52-week high.
Market & Competitive Risks: The stock's forward P/E of 11.6x is reasonable but not cheap, and the P/B of 1.43x is near the high end of its 5-year range, leaving it vulnerable to multiple compression if the market turns risk-off. With a beta of 0.92, the stock is moderately correlated to the market, meaning a broad downturn could pressure the stock. Competitive risks include regional bank consolidation and margin compression from a higher-for-longer rate environment. Recent news highlights the merger's potential, but any regulatory or execution setbacks could shift sentiment. The wide analyst target range (18% spread) underscores uncertainty.
Worst-Case Scenario: In a worst-case scenario, integration challenges lead to cost overruns and revenue synergies fail to materialize, causing earnings to fall to the low estimate of $4.39. Combined with a de-rating to a P/E of 11.0x (below current), the stock could drop to $48.29, a 15.5% decline from $57.16. If the broader market also corrects, the stock could approach its 52-week low of $40.05, representing a 30% loss. This scenario would likely involve a recession or severe credit cycle, but the company's strong free cash flow and lower debt provide some downside protection.
FAQ
The key risks are: 1) Integration risk from the Comerica merger, which could lead to cost overruns and missed synergies. 2) Revenue growth deceleration, with YoY growth slowing to 1.4% in Q4 2025. 3) Valuation risk, as the P/B of 1.43x is near historical highs, leaving room for multiple compression. 4) Macro risk, as higher-for-longer interest rates could compress net interest margins. The most severe risk is integration failure, which could drive the stock to $50.90 (11% downside) or lower.
The 12-month forecast is mixed. The base case (50% probability) sees the stock trading between $55 and $62, with EPS of $5.37. The bull case (25% probability) targets $62-$70, driven by successful merger execution. The bear case (25% probability) sees $44-$51, if integration fails. The most likely scenario is the base case, with the stock near $62, implying 9% upside. However, the wide range reflects high uncertainty, and the stock's current price near $57.16 already prices in moderate success.
FITB appears fairly valued. The forward P/E of 11.6x is in line with regional bank peers (typically 10-14x) and below its historical peak of 15.0x. The PEG ratio of 1.07x suggests the stock is reasonably priced relative to its expected earnings growth. However, the P/B ratio of 1.43x is near the high end of its 5-year range (0.99x-1.47x), indicating the market is pricing in improved returns. Overall, the stock is not cheap but not overvalued, reflecting optimism around the merger.
FITB is a reasonable buy for investors with a medium-term horizon who believe in the Comerica merger thesis. The stock offers a 3.74% dividend yield, a forward P/E of 11.6x, and analyst upside of 9% to the average target. However, the stock is near its 52-week high, limiting near-term gains. The biggest downside risk is integration failure, which could send the stock to $50.90 (11% downside). For risk-tolerant investors, it's a buy on pullbacks; for conservative investors, it's a Hold until merger benefits become clearer.
FITB is more suitable for medium-to-long-term investment (12-24 months) given the merger thesis. The stock has a beta of 0.92, indicating slightly lower volatility than the market, and a 3.74% dividend yield provides income. Short-term trading is risky due to the stock's proximity to its 52-week high and potential for profit-taking. A minimum holding period of 12 months is recommended to allow the merger benefits to materialize. Long-term investors should monitor integration progress and revenue growth for signs of success.